Global Brain Cancer Therapeutics Market
Overview:
Brain cancer is the overgrowth of cells in the brain forming masses which are known as tumors. This is a type of brain disorder where cancer cells arise in the brain tissue and these cells can multiply for producing a tumor. This tumor interferes with normal functions of the brain like sensation, muscle control and memory. Primary brain tumors can be developed from various brain tissues like astrocytes or glial cells.
Global brain cancer therapeutics market is forecast to be valued at US$ 2,539.0 million in 2021 over the forecast period.
𝐓𝐨 𝐆𝐞𝐭 𝐌𝐨𝐫𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 Free 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭: @ https://www.coherentmarketinsights.com/insight/request-sample/4769
Impact of COVID-19:
The COVID-19 pandemic has drastically affected several clinical trials. Various trials have paused enrollment, and researchers are facing multiple challenges associated with setting up remote visits, and performing laboratory and other study assessments.
The top three practices in cancer therapy that have been most influenced by the COVID-19 epidemic are surgery delays, chemo delays, and a reduction in the number of biopsies.
In cancer, early diagnosis and rapid treatment are important to reduce mortality and enhance survival. As a result, if the healthcare system struggles to bring cancer treatment back to its previous levels of efficiency, it can put cancer patients at risk.
Moreover, regulatory approvals for brain cancer therapeutics is also expected to aid in the growth of the global brain cancer therapeutics market over the forecast period. For instance, on April 10, 2018, the U.S. Food and Drug Administration (FDA) approved everolimus tablets for oral suspension (Afinitor Disperz, Novartis Pharmaceuticals Corp.) for the adjunctive treatment of adult and pediatric patients aged 2 years and older with tuberous sclerosis complex (TSC)-associated partial-onset seizures. Everolimus is also approved for two other manifestations of TSC: TSC-associated subependymal giant cell astrocytoma (SEGA) and TSC-associated renal angiomyolipoma.
𝐃𝐨 𝐘𝐨𝐮 𝐇𝐚𝐯𝐞 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭? 𝐀𝐬𝐤 𝐓𝐨 𝐎𝐮𝐫 𝐄𝐱𝐩𝐞𝐫𝐭𝐬: https://www.coherentmarketinsights.com/insight/talk-to-analyst/4769
Drivers:
Increasing new drug launches and rising funding from government from government is anticipated to fuel growth of the global brain cancer therapeutics market during the forecast period. For instance, an oncologist in Mayo Clinic in Rochester, Minnesota gained US$ 1 million funding for carrying out phase 1 study of WSD0922-FU, in October 2021. This treatment can be used for blocking the epidermal growth factor receptor protein while treating astrocytoma.
Key Takeaways:
- The global brain cancer therapeutics market is anticipated to exhibit a CAGR of 9.8% over the forecast period, owing to increasing research and developmental activities by pharma companies. For instance, Lantern Pharma has declared their partnership with Kennedy Krieger Institute and Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in December 2020, and this was announced using their RADR artificial intelligence platform. They will be focusing on of Lantern’s LP-184 used in glioblastoma multiforme treatment.
- Targeted therapy segment, among treatment type in the global brain cancer therapeutics market is anticipated to witness robust growth over the forecast period, due to rising awareness with respect to precision of the medicine. For instance, in September 2020, the U.S. Food and Drug Administration has approved a biosimilar drug used for the treatment of cancer. Mvasi, a biosimilar product works just like Avastin, which interferes with blood vessels during growth of cancer, this is known as monoclonal antibody and is a type of targeted therapy. Whereas, Mvasi works in a similar manner and it is much cheaper.
- North America is estimated to witness significant growth in the global brain cancer therapeutics market over the forecast period, due to rising development in the healthcare industry along with rising incidences of brain cancer and increasing technological advancements in the region. For instance, a report by the American Society of Clinical Oncology in 2021 suggested that almost 24,530 individuals were diagnosed with cancerous tumor in the brain and spinal cord, which consisted of 10,690 women and 13,840 men.
Key Players:
Major players operating in the global brain cancer therapeutics market include Amgen Inc., AstraZeneca PLC, F. Hoffmann-La Roche Ltd, Pfizer Inc., GlaxoSmithKline PLC, Novartis AG, Johnson & Johnson, Merck & Co, Bayer AG, and Bristol-Myers Squibb Company
𝐆𝐫𝐚𝐛 𝐭𝐡𝐞 𝐎𝐟𝐟𝐞𝐫 𝐚𝐧𝐝 𝐆𝐞𝐭 𝐅𝐋𝐀𝐓 𝟑𝟎% 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐧 𝐓𝐡𝐢𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝟐𝟎𝟐𝟐-𝟐𝟎𝟐𝟖 @ https://www.coherentmarketinsights.com/promo/buynow/4769
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Indication
- Market Snapshot, By Treatment Type
- Market Snapshot, Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Pipeline Analysis
- Regulatory Scenario
- Market Trends
- Key Developments
- Epidemiology
- PEST Analysis
- Brand Analysis
- Market Dynamics
- Global Brain Cancer Therapeutics Market– Impact of Coronavirus (COVID-19) Pandemic
- Economic Impact
- Impact on Clinical Trials and Drug Development
- Government Initiatives
- Global Brain Cancer Therapeutics Market, By Indication, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Glioblastoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Meningioma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Pituitary Tumors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Brain Cancer Therapeutics Market, By Treatment Type, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Targeted Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Brain Cancer Therapeutics Market, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/brain-cancer-therapeutics-market-4022
𝗔𝗯𝗼𝘂𝘁 𝗨𝗦:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝗨𝘀:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837